EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis

Sutopa Roy, Srija Moulik, Madhurima Roy, Manab K Ghosh, Surya Jyati Chaudhuri, Dhruv K Pandey, Saurabh Jain, Daniel Argaw Dagne, Mitali Chatterjee

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.23-0197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Sutopa Roy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, India. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Leishmaniasis, Cutaneous, Leishmania, Leishmania donovani. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-kala-azar dermal leishmaniasis (PKDL), the dermal sequel to visceral leishmaniasis (VL), is characterized by hypopigmented macules (macular) and/or papules and nodules (polymorphic). Post-kala-azar dermal leishmaniasis plays a significant role in disease transmission, emphasizing the need for monitoring chemotherapeutic effectiveness. Accordingly, this study aimed to quantify the parasite burden in PKDL patients after treatment with miltefosine by a quantitative polymerase chain reaction (qPCR). A Leishmania kinetoplastid gene-targeted qPCR was undertaken using DNA from skin biopsy specimens of patients with PKDL at three time points, i.e., at disease presentation (week 0, n = 157, group 1), upon completion of treatment (week 12, n = 39, group 2), and at any time point 6 months after completion of treatment (week ≥36, n = 54, group 3). A cycle threshold ( Ct ) 30. The parasite load at disease presentation (group 1) was 10,769 (1,339–80,441)/µg gDNA (median [interquartile range]). In groups 2 and 3, qPCR results were negative in 35/39 cases (89.7%) and 48/54 cases (88.8%), respectively. In the 10/93 (10.8%) qPCR-positive cases, the parasite burdens in groups 2 and 3 were 2,420 (1,205–5,661)/µg gDNA and 22,195 (5,524–100,106)/µg gDNA, respectively. Serial monitoring was undertaken in 45 randomly selected cases that had completed treatment; all cases in groups 2 or 3 had a Ct >30, indicating cure. Overall, qPCR confirmed an 89.2% cure (as 83/93 cases showed parasite clearance), and the persistent qPCR positivity was attributed to nonadherence to treatment or unresponsiveness to miltefosine and remains to be investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralLeishmaniasis, CutaneousLeishmaniaLeishmania donovaniHumansDNAPhosphorylcholine

Substanzen

miltefosineDNAPhosphorylcholine

Autor:innen und Institutionen

  • Department of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, India.
  • Department of Tropical Medicine, School of Tropical Medicine, Kolkata, India.
  • Department of Microbiology, Sarat Chandra Chattopadhyay Government Medical College and Hospital, Howrah, India.
  • Kala-Azar Elimination Programme, World Health Organization Country Office, New Delhi, India.
  • Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Förderung

  • World Health Organization

Zitieren

APA

Roy, S., Moulik, S., Roy, M., Ghosh, M. K., Chaudhuri, S. J., Pandey, D. K., Jain, S., Dagne, D. A., & Chatterjee, M. (2024). Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0197

Vancouver

Roy S, Moulik S, Roy M, Ghosh MK, Chaudhuri SJ, Pandey DK, et al. Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0197

BibTeX
@article{Roy2024,
  author = {Roy, Sutopa and Moulik, Srija and Roy, Madhurima and Ghosh, Manab K and Chaudhuri, Surya Jyati and Pandey, Dhruv K and Jain, Saurabh and Dagne, Daniel Argaw and Chatterjee, Mitali},
  title = {Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.23-0197}
}
Kostenlos starten →